Siri Lillegraven Selected Research

Siri Lillegraven Research Topics

21	Rheumatoid Arthritis 04/2024 - 10/2007
4	Inflammation (Inflammations) 01/2022 - 12/2017
4	Rheumatic Diseases (Rheumatism) 01/2018 - 08/2016
3	Fatigue 01/2022 - 10/2007
1	Sudden Death 04/2024
1	Axial Spondyloarthritis 12/2023
1	Ankylosing Spondylitis 12/2023
1	Infections 01/2022
1	Necrosis 01/2022
1	Psoriatic Arthritis 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Obesity 01/2019
1	Ankylosis 09/2011
1	Osteoarthritis 06/2011
1	Arthritis (Polyarthritis) 10/2007

12	Antirheumatic Agents (DMARD)IBA 04/2024 - 08/2016
4	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2020
2	amsonic acid (DAS)IBA 01/2022 - 01/2022
2	Prostaglandins AIBA 01/2022 - 01/2022
2	GlucocorticoidsIBA 01/2019 - 01/2018
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2018 - 12/2017
1	Tumor Necrosis Factor InhibitorsIBA 12/2023
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Anti-Citrullinated Protein AntibodiesIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	dimemorfan (AT 17)IBA 09/2011
1	4-hexyloxyaniline (HOA)IBA 06/2011
1	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 10/2007
1	ametantrone (HAQ)IBA 10/2007